{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:34:35Z","timestamp":1791729275277,"version":"4.3.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/mnm.0b013e32805b72a0","type":"journal-article","created":{"date-parts":[[2007,2,26]],"date-time":"2007-02-26T04:06:36Z","timestamp":1172462796000},"page":"245-250","source":"Crossref","is-referenced-by-count":70,"title":["89Sr versus 153Sm-EDTMP: Comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma"],"prefix":"10.1097","volume":"28","author":[{"given":"Maciej","family":"B\u0105czyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Czepczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Milecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Pisarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Oleksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Sowi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210212","first-page":"64","article-title":"Diagnosis of skeletal metastases and assessment of response to treatment","volume":"312","author":"Galasko","year":"1995","journal-title":"Clin Orthop Relat Res"},{"key":"R2-3-20210212","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1991.9.3.509","article-title":"Bone metastases: pathophysiology and management policy","volume":"9","author":"Nielsen","year":"1991","journal-title":"J Clin Oncol"},{"issue":"suppl 11","key":"R3-3-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0093-7754(01)90229-5","article-title":"Bone metastases: approaches to management","volume":"28","author":"Janjan","year":"2001","journal-title":"Semin Oncol"},{"key":"R4-3-20210212","first-page":"655","article-title":"Advances in our understanding of the treatment of painful metastases","volume":"41","author":"Silberstein","year":"2000","journal-title":"J Nucl Med"},{"key":"R5-3-20210212","first-page":"1","article-title":"Radionuclide treatment of bone metastases \u2013 current concepts and trends","volume":"4","author":"Lass","year":"2001","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"R6-3-20210212","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(05)70206-0","article-title":"Radioisotopes for the palliation of metastatic bone cancer: a systemic review","volume":"6","author":"Finlay","year":"2005","journal-title":"Lancet Oncol"},{"key":"R7-3-20210212","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/01.coc.0000135378.67644.ba","article-title":"The correlation between palliation of bone pain by intravenous strontium-89 and external beam radiation to linked field in patients with osteoblastic bone metastases","volume":"27","author":"Ron","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"R8-3-20210212","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0302-2838(03)00364-6","article-title":"Strontium (89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer. Genitourinary Group","volume":"44","author":"Oosterhof","year":"2003","journal-title":"Eur Urol"},{"key":"R9-3-20210212","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.semnuclmed.2004.11.006","article-title":"Teletherapy and radiopharmaceutical therapy of painful bone metastases","volume":"35","author":"Silberstein","year":"2005","journal-title":"Semin Nucl Med"},{"key":"R10-3-20210212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1053-4296(00)80047-8","article-title":"Use of radionuclides for the palliation of bone metastases","volume":"10","author":"McEwan","year":"2000","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"R11-3-20210212","first-page":"38S","article-title":"Bone-seeking radionuclides for therapy","volume":"46","author":"Lewington","year":"2005","journal-title":"J Nucl Med"},{"key":"R12-3-20210212","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.radonc.2005.03.003","article-title":"Radiopharmaceuticals for the palliation of painful bone metastasis \u2013 a systemic review","volume":"75","author":"Bauman","year":"2005","journal-title":"Radiother Oncol"},{"key":"R13-3-20210212","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiographics.9.2.2467331","article-title":"Strontium-89: Treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone","volume":"9","author":"Robinson","year":"1989","journal-title":"Radiographics"},{"key":"R14-3-20210212","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s002590100533","article-title":"A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer","volume":"28","author":"Dafermou","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"R15-3-20210212","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1200\/JCO.1998.16.4.1574","article-title":"Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam; a double-blind placebo-controlled clinical trial","volume":"16","author":"Serafini","year":"1998","journal-title":"J Clin Oncol"},{"key":"R16-3-20210212","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0969-8043(00)00159-7","article-title":"ESR dosimetry of 89Sr and 153Sm in bone","volume":"54","author":"Kinoshita","year":"2001","journal-title":"Appl Radiat Isot"},{"key":"R17-3-20210212","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1200\/JCO.2005.01.2310","article-title":"Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy","volume":"23","author":"Tu","year":"2005","journal-title":"J Clin Oncol"},{"key":"R18-3-20210212","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s002590000315","article-title":"Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement","volume":"27","author":"Kraeber-Bodere","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"R19-3-20210212","first-page":"1902","article-title":"Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides","volume":"36","author":"O'Donoghue","year":"1995","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0b013e32805b72a0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:29:28Z","timestamp":1786033768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-200704000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e32805b72a0","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}